Loss of Asthma Control in Pediatric Patients after Discontinuation of Long-Acting Beta-Agonists

Table 1

Baseline patient characteristics.

	All
Patients, n	54
Age, y	10.9 (6–18)
Male sex (%)	33 (61%)
Caucasian race (%)	44 (81%)
Duration of asthma, yr	7.4 (1–15)
LTRA use (%)	25 (46%)
ACT	23.5±1.9
FVC, % predicted	104.8±11.6
FEV1, % predicted	102.3±11.8
FEF25-75, % predicted	98.1±24.7

Abbreviations—LTRA: leukotriene receptor antagonists; ACT: asthma control test; FVC: forced vital capacity; FEV₁: forced expiratory volume in 1 second; FEF_25-75: forced expiratory flow at 25–75% of FVC.